Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA] class drugs

2 results
  • gomekli - mirdametinib capsule

    (Mirdametinib)
    Springworks Therapeutics, Inc.
    Gomekli treats adults and children 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas that cannot be completely removed by surgery.
  • koselugo - selumetinib capsule

    (Selumetinib)
    Astrazeneca Pharmaceuticals Lp
    Koselugo treats adults and children aged 1 year and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas.